Overall rank by patents
#4,185
of 49,997 tracked assignees
USPTO PatentsView assignee record - 85 granted patents across 48 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Boehringer ranks #4,185 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 48 technology areas.
USPTO PatentsView assignee plate
Corpus R4185 · US Corporation #4,185 · 85 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: ArthroCare Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Biotronik · near
53 score
Boehringer Ingelheim… · this assignee
53 score
GD Energy Products · near
53 score
Hatch · near
53 score
HCL America · near
53 score
3D Lighting… · lowest
7 score
What this shows Boehringer's Innovation Score is 52.8/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Boehringer Ingelheim Animal Health USA Inc. is a focused PatentsView assignee: 48 CPC subclasses with 67.1% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (29 grants) versus a trough of 8 in 2021. By volume, Boehringer sits between ArthroCare Corporation and Construction Research & Technology GMBH.
From 2019–2021 to 2022–2024, Boehringer Ingelheim Animal Health USA Inc. moved from 56 to 26 grants (0.46x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ArthroCare Corporation
85 patents
Avalara, Inc.
85 patents
Beijing Jingdong Qianshi Technology Co., Ltd.
85 patents
Biomarin Pharmaceutical Inc.
85 patents
Bitdefender IPR Management Ltd.
85 patents
Changzhou University
85 patents
Chemetall GMBH
85 patents
Construction Research & Technology GMBH
85 patents
Boehringer Ingelheim Animal Health USA Inc.
85 patents
What this shows Boehringer holds 85 patents at rank #4,184, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,184 in granted patent volume.
Other assignees with the most granted patents in Boehringer's primary technology class.
Two PlainPatent-derived peer sets for Boehringer, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (53 here).
Nearest assignees by average claims per patent (16.4 here).
Boehringer's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 19 | 22.4% |
| 2020 | 29 | 34.1% |
| 2021 | 8 | 9.4% |
| 2022 | 10 | 11.8% |
| 2023 | 8 | 9.4% |
| 2024 | 8 | 9.4% |
| 2025partial year | 3 | 3.5% |
Top 15 of 48 technology areas
Overall rank by patents
#4,185
of 49,997 tracked assignees
52.8 out of 100
What to do with this data
Boehringer Ingelheim Animal Health USA Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.